Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ

308.44

+15.03(+5.12%)

Updated at December 20 04:00PM

Currency In USD

Valuation

Market Cap4.32B
Enterprise Value4.34B
P/E Ratio-12.93
PEG Ratio-7.85
Price/Sales Ratio86.71
Price/Book Ratio8.63
Enterprise/Revenue85.25
Enterprise/EBITDA-13.16

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-6.69
Operating Margin-7.06

Management Effectiveness

Return On Assets-0.48
Return On Equity-0.72

Income Statement

Revenue0
Revenue/Share3.57
Gross Profit-527,000
EBITDA-379.97M
Net Income-373.63M
Diluted EPS-19.99

Balance Sheet

Total Cash998.63M
Total Cash/Share45.92
Total Debt119.14M
Total Debt/Equity0.15
Current Ratio5.98
Book Value Per Share35.74

Price History

52-Week Change38.75
52-Week High368.29
52-Week Low168.25
Moving Average 50 Days286.92
Moving Average 200 Days256.7

Statistics

Average Volume420,309
Shares Outstanding21.81M
% Held by Institutions103.92

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:35
Last Split DateJuly 25, 2016